文献速递口腔修复与种植口腔正畸

锶修饰钛表面通过上调CDH2促进MSCs成骨分化与种植体骨整合

Strontium-modified titanium substrate promotes osteogenic differentiation of MSCs and implant osseointegration via upregulating CDH2.
PubMed 文献 · Clin Oral Implants Res · 2023-02-12

本研究探讨锶修饰喷砂大颗粒酸蚀钛表面(Sr-SLA)促进骨整合的机制,通过全转录组测序筛选出CDH2为关键介导因子。体外用慢病毒沉默MSCs中CDH2,体内用AAV9-CDH2i静脉注射小鼠后行胫骨植体手术,micro-CT监测骨整合。结果表明CDH2是Sr-SLA介导骨再生所必需,靶向CDH2的生物材料修饰可能有助于改善早期骨整合与骨愈合。

要点

  • Sr-SLA上调MSCs中CDH2表达,伴随细胞迁移、黏附和早期成骨标志物上调。
  • 敲低CDH2降低MSCs活力和成骨分化,Sr-SLA的生物相容性和骨诱导效应被大幅削弱。
  • Sr-SLA同时促进β-catenin表达和核转位,CDH2上调未伴随β-catenin信号受限。

核心结论

  • CDH2是Sr-SLA介导骨再生所必需的,揭示了Sr-SLA骨诱导效应的新机制。
  • 靶向CDH2的生物材料修饰可能有助于改善早期骨整合和骨愈合。

研究设计与样本

  • 对种植体周围骨组织行全转录组RNA测序,筛选CDH2为Sr-SLA介导骨整合的关键介导因子。
  • 体外用慢病毒载体沉默MSCs中CDH2基因后接种于钛基底,评估对MSCs活力、分化和β-catenin信号活性的影响。
  • 体内将携带靶向CDH2的人工siRNA的AAV9载体(AAV9-CDH2i)静脉注射小鼠,随后行胫骨手术植入植体,用micro-CT分析骨整合。

主要发现

  • Sr-SLA上MSCs的CDH2表达高于对照组,与细胞迁移、黏附增强及早期成骨标志物上调相平行。
  • 敲低MSCs中CDH2导致细胞活力和成骨分化下降,Sr-SLA升高的生物相容性和骨诱导效应被大幅削弱。
  • Sr-SLA诱导的CDH2上调未伴随β-catenin信号受限,因Sr-SLA同时促进β-catenin表达和核转位。
  • 全身给予AAV9-CDH2i有效敲低骨髓细胞中CDH2表达,进而抑制Sr-SLA诱导的骨形成。

临床怎么用

  • 作者认为,靶向CDH2的生物材料修饰可能有助于改善早期骨整合和骨愈合。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Our previous studies showed that strontium (Sr)-modified sand-blasted, large grit, acid etched titanium surface (Sr-SLA) is beneficial for osseointegration; however, the supporting mechanisms have not been explored in detail. MATERIALS AND METHODS: Whole-transcriptome RNA sequencing of peri-implant bone tissue was performed, and CDH2 was selected as a key mediator of Sr-SLA-mediated osseointegration. To test this hypothesis, a lentivirus-mediated vector targeting the silencing of the CDH2 gene was used in mesenchymal stem cells (MSCs) prior to seeding on Ti substrates. The effects of CDH2 interference on MSCs vitality, differentiation, and β-catenin signaling activity were evaluated. In vivo, a recombinant adeno-associated virus 9 vector carrying an artificial siRNA that target CDH2 (AAV9-CDH2i) was intravenously injected in mice, followed by tibial surgery with implant placement. Osseointegration were monitored using micro-CT analysis. RESULTS: CDH2 expression in MSCs on Sr-SLA was higher than the control group, which was in parallel with the enhanced cell migration, adhesion, and upregulation of early osteogenic markers. Knocking down CDH2 in MSCs resulted in decreased cell viability and osteogenic differentiation, and the elevated biocompatibility and osteoinductive effect of Sr-SLA were greatly diminished. Surprisingly, Sr-SLA-induced upregulation of CDH2 was not followed by restriction of β-catenin signaling because Sr-SLA also promoted the expression and nuclear translocation of β-catenin. Systemic administration of AAV9-CDH2i effectively knocked down CDH2 expression in bone marrow cells, and in turn, inhibited bone formation induced by Sr-SLA. CONCLUSIONS: The results indicated that CDH2 is required for Sr-SLA-mediated bone regeneration, which reveals a new mechanism to explain the osteoinductive effect of Sr-SLA. Thus, biomaterial modifications targeting CDH2 may help improve early osseointegration and bone healing.

来源:Clin Oral Implants Res,查看原文。版权归原作者所有。

引用

  1. Zhou C, Ge Z, Song L, et al. Strontium-modified titanium substrate promotes osteogenic differentiation of MSCs and implant osseointegration via upregulating CDH2. Clin Oral Implants Res. 2023. PMID: 36691814. doi:10.1111/clr.14035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。